ProQR Therapeutics N.V. Cash Flows From Used In Financing Activities
ProQR Therapeutics N.V. (PRQR) reported Cash Flows From Used In Financing Activities of -EUR 1.84 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-12
- ProQR Therapeutics N.V. cash flows from used in financing activities for the quarter ending 2025-12-31 was -599.00K EUR, a 100.84% decline year-over-year.
- ProQR Therapeutics N.V. cash flows from used in financing activities for the quarter ending 2025-09-30 was -444.00K EUR.
- ProQR Therapeutics N.V. cash flows from used in financing activities for the quarter ending 2025-06-30 was -293.00K EUR.
- ProQR Therapeutics N.V. cash flows from used in financing activities for the quarter ending 2025-03-31 was -500.00K EUR.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 9 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -599.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -1.04M EUR derived: sum of 2 quarters · filed 2026-03-12 | -1.34M EUR derived: sum of 3 quarters · filed 2026-03-12 | -1.84M EUR 20-F · filed 2026-03-12 |
| 2025-09-30 | -444.00K EUR 6-K · filed 2025-11-06 | -737.00K EUR derived: sum of 2 quarters · filed 2025-11-06 | -1.24M EUR 6-K · filed 2025-11-06 | 70.19M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | -293.00K EUR 6-K · filed 2025-08-07 | -793.00K EUR 6-K · filed 2025-08-07 | 70.64M EUR derived: sum of 3 quarters · filed 2026-03-12 | 70.18M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | -500.00K EUR 6-K · filed 2025-05-08 | 70.93M EUR derived: sum of 2 quarters · filed 2026-03-12 | 70.48M EUR derived: sum of 3 quarters · filed 2026-03-12 | 70.19M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | 71.43M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 70.98M EUR derived: sum of 2 quarters · filed 2026-03-12 | 70.69M EUR derived: sum of 3 quarters · filed 2026-03-12 | 70.28M EUR 20-F · filed 2026-03-12 |
| 2024-09-30 | -453.00K EUR 6-K · filed 2025-11-06 | -735.00K EUR derived: sum of 2 quarters · filed 2025-11-06 | -1.15M EUR 6-K · filed 2025-11-06 | -2.25M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -282.00K EUR 6-K · filed 2025-08-07 | -701.00K EUR 6-K · filed 2025-08-07 | -1.79M EUR derived: sum of 3 quarters · filed 2026-03-12 | -2.07M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -419.00K EUR 6-K · filed 2025-05-08 | -1.51M EUR derived: sum of 2 quarters · filed 2026-03-12 | -1.79M EUR derived: sum of 3 quarters · filed 2026-03-12 | -2.44M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -1.09M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -1.37M EUR derived: sum of 2 quarters · filed 2026-03-12 | -2.02M EUR derived: sum of 3 quarters · filed 2026-03-12 | -2.27M EUR 20-F · filed 2026-03-12 |
| 2023-09-30 | -281.00K EUR 6-K · filed 2024-11-07 | -924.00K EUR derived: sum of 2 quarters · filed 2024-11-07 | -1.18M EUR 6-K · filed 2024-11-07 | 12.58M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -643.00K EUR 6-K · filed 2024-08-08 | -902.00K EUR 6-K · filed 2024-08-08 | 12.86M EUR derived: sum of 3 quarters · filed 2025-03-13 | -30.89M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | -259.00K EUR 6-K · filed 2024-05-09 | 13.51M EUR derived: sum of 2 quarters · filed 2025-03-13 | -30.25M EUR derived: sum of 3 quarters · filed 2025-03-13 | -30.61M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | 13.76M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | -29.99M EUR derived: sum of 2 quarters · filed 2025-03-13 | -30.35M EUR derived: sum of 3 quarters · filed 2025-03-13 | -30.89M EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | -43.75M EUR 6-K · filed 2023-11-07 | -44.11M EUR derived: sum of 2 quarters · filed 2023-11-07 | -44.65M EUR 6-K · filed 2023-11-07 | -17.71M EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -357.00K EUR 6-K · filed 2023-08-03 | -900.00K EUR 6-K · filed 2023-08-03 | 26.04M EUR derived: sum of 3 quarters · filed 2023-08-03 | 49.61M EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -543.00K EUR 6-K · filed 2023-05-16 | 26.40M EUR derived: sum of 2 quarters · filed 2023-05-16 | 49.96M EUR derived: sum of 3 quarters · filed 2023-05-16 | 133.30M EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | 26.94M EUR 6-K · filed 2022-02-24 | 50.51M EUR derived: sum of 2 quarters · filed 2022-11-09 | 133.85M EUR derived: sum of 3 quarters · filed 2022-11-09 | 136.83M EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | 23.56M EUR 6-K · filed 2022-11-09 | 106.90M EUR derived: sum of 2 quarters · filed 2022-11-09 | 109.89M EUR 6-K · filed 2022-11-09 | 110.08M EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 83.34M EUR 6-K · filed 2022-08-04 | 86.33M EUR 6-K · filed 2022-08-04 | 86.52M EUR derived: sum of 3 quarters · filed 2022-08-04 | 99.78M EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 2.98M EUR 6-K · filed 2022-05-05 | 3.18M EUR derived: sum of 2 quarters · filed 2022-05-05 | 16.44M EUR derived: sum of 3 quarters · filed 2022-05-05 | 16.93M EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 197.00K EUR 6-K · filed 2022-02-24 | 13.45M EUR derived: sum of 2 quarters · filed 2022-02-24 | 13.94M EUR derived: sum of 3 quarters · filed 2022-02-24 | 14.50M EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | 13.25M EUR 6-K · filed 2021-11-04 | 13.75M EUR derived: sum of 2 quarters · filed 2021-11-04 | 14.30M EUR 6-K · filed 2021-11-04 | 64.51M EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | 492.00K EUR 6-K · filed 2021-08-05 | 1.05M EUR 6-K · filed 2021-08-05 | 51.25M EUR derived: sum of 3 quarters · filed 2021-08-05 | 50.97M EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 557.00K EUR 6-K · filed 2020-05-07 | 50.76M EUR derived: sum of 2 quarters · filed 2021-02-25 | 50.47M EUR derived: sum of 3 quarters · filed 2021-02-25 | 50.28M EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | 50.20M EUR 6-K · filed 2021-02-25 | 49.92M EUR derived: sum of 2 quarters · filed 2021-02-25 | 49.72M EUR derived: sum of 3 quarters · filed 2021-02-25 | 50.20M EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | -288.00K EUR 6-K · filed 2020-11-16 | -482.00K EUR derived: sum of 2 quarters · filed 2020-11-16 | -5.00K EUR 6-K · filed 2020-11-16 | 966.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | -194.00K EUR 6-K · filed 2020-08-06 | 283.00K EUR 6-K · filed 2020-08-06 | 1.25M EUR derived: sum of 3 quarters · filed 2021-03-24 | 86.30M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | 477.00K EUR 6-K · filed 2020-05-07 | 1.45M EUR derived: sum of 2 quarters · filed 2021-03-24 | 86.50M EUR derived: sum of 3 quarters · filed 2021-03-24 | 86.63M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | 971.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | 86.02M EUR derived: sum of 2 quarters · filed 2021-03-24 | 86.16M EUR derived: sum of 3 quarters · filed 2021-03-24 | 86.46M EUR 20-F · filed 2021-03-24 |
| 2018-09-30 | 85.05M EUR 6-K · filed 2019-11-12 | 85.19M EUR derived: sum of 2 quarters · filed 2019-11-12 | 85.49M EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | 138.00K EUR 6-K · filed 2019-08-07 | 439.00K EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | 26.64M EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | 1.17M EUR 6-K · filed 2018-08-08 | 3.33M EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | 357.00K EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | 1.62M EUR 20-F · filed 2018-03-30 |